Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 August 2004, Vol. 104, No. 4, pp. 932.
Prepublished online as a Blood First Edition Paper on July 8, 2004; DOI 10.1182/blood-2003-11-3774.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-3774v1
2003-11-3774v2
104/4/932    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, I. M.
Right arrow Articles by Reed, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, I. M.
Right arrow Articles by Reed, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RETRACTION

Retraction: The triterpenoid CDDO-Imidazolide induces apoptosis and enhances fludarabine-induced apoptosis of CLL B-cells

Irene M. Pedersen, Juan M. Zapata, Temesgen Samuel, Fiona L. Scott, Guy S. Salvesen, Tadashi Honda, Gordon W. Gribble, Nanjoo Suh, Michael B. Sporn, Thomas J. Kipps, and John C. Reed

Re: Pedersen IM, Zapata JM, Samuel T, et al. The triterpenoid CDDO-Imidazolide induces apoptosis and enhances fludarabine-induced apoptosis of CLL B-cells. Blood First Edition Paper, prepublished online January 22, 2004; DOI 10.1182/blood-2003-11-3774. We retract this prepublished paper. Upon analysis of additional CLL patient specimens since the original submission, the effects of CDDO-IM on fludarabine-induced apoptosis have proven to be highly variable. A larger collection of patient specimens must eventually be analyzed to obtain a clearer picture of the cellular effects and molecular mechanisms of CDDO-IM in CLL B cells.

Irene M. Pedersen, Juan M. Zapata, Temesgen Samuel, Fiona L. Scott, Guy S. Salvesen, Tadashi Honda, Gordon W. Gribble, Nanjoo Suh, Michael B. Sporn, Thomas J. Kipps, and John C. Reed (authors)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-3774v1
2003-11-3774v2
104/4/932    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, I. M.
Right arrow Articles by Reed, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, I. M.
Right arrow Articles by Reed, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020